Indomethacin and cerebral blood flow in premature infants treated for patent ductus arteriosus.
Central blood flow (CBF) was estimated by an intravenous 133-xenon technique in six preterm infants before and after administration of indomethacin for closure of patent ductus arteriosus. CBF fell in all infants (range 12%-40%), the mean fall was 24% (P less than 0.005). Though none of the infants showed signs of impaired cerebral function during or following the injections, the results do not indicate whether or not the use of indomethacin is a potential hazard.
Pryds
O
O
Department of Neonatology, State University Hospital of Copenhagen, Rigshospitalet, Denmark.
Greisen
G
G
Johansen
K H
KH
D002560:Cerebrovascular Circulation / Q000187:drug effects*; D004374:Ductus Arteriosus, Patent / Q000188:drug therapy / Q000503:physiopathology*; D006801:Humans; D007213:Indomethacin / Q000009:adverse effects / Q000494:pharmacology*; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000188:drug therapy / Q000503:physiopathology*
D007213:Indomethacin